Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(38%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_3
1
13%
Ph not_applicable
2
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(4)
Other(1)

Detailed Status

Completed4
Recruiting3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (33.3%)
N/A2 (66.7%)

Trials by Status

recruiting338%
completed450%
unknown113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
8